NIH-funded research Training grant

Training in pediatric blood disorder research

Official title: Basic and Translational Research Training in Pediatric Classical Hematology

Funded at St. Jude Children's Research Hospital · NIH-11016782 · Data updated 2026-11-12

This study is all about helping kids with blood disorders like sickle cell disease by training new researchers to find better treatments and therapies for these conditions.

Quick facts

Grant typeTraining grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$252,285
NIH project number1T32HL176447-01
Project IDNIH-11016782 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research are children diagnosed with non-malignant blood disorders.

Less likely to help

Patients with malignant blood disorders or those outside the pediatric age range may not receive benefit from this research.

What this research studies

This research focuses on improving our understanding of non-malignant blood disorders in children, such as sickle cell disease and inherited bone marrow failure syndromes. It aims to train new biomedical researchers in Classical Hematology, equipping them with the skills needed to make significant biological discoveries. The program will support postdoctoral fellows who will engage in both basic and translational research, ultimately contributing to the development of new therapies for these conditions. By fostering a new generation of researchers, the initiative seeks to address the critical shortage of experts in this vital field.

Why it matters

Potential benefit: If successful, this research could lead to the development of new and effective therapies for pediatric blood disorders.

How similar studies have gone: Previous research in similar areas has shown promise, particularly in the development of therapies for sickle cell disease through genome editing.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Mckinney-Freeman, Shannon L — St. Jude Children's Research Hospital
  • Study coordinator: Mckinney-Freeman, Shannon L

Related research

Other NIH-funded projects on the same topics.

  • Investigating frailty and aging in childhood cancer survivors

    This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9890475

  • Investigating a specific type of leukemia in children caused by genetic changes.

    This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9834651

  • Accessible, label-free optical imaging to reveal disease signals

    A brain-friendly, patient-centered imaging approach aims to uncover hidden disease signals in cells and tissues without labels or dyes.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11627327

  • Targeting the SCP4 pathway in acute myeloid leukemia (AML)

    Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11617813

  • Blocking cancer-causing cMYC tricks after pregnancy changes in the breast

    Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11615605

  • Targeting aberrant enhancer landscapes in pancreatic cancer

    A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11611138

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.